BCL6 fine-tunes long-term tumor control.

Sun et al. provide comprehensive evidence that the transcription factor BCL6 functions as a gatekeeper for CD8 + progenitor cell function in tumors and prevents their excessive terminal differentiation, thereby preserving this stem-like population for long-term tumor control.